Last updated: March 6, 2026
What is the Scope of Patent ES2901785?
Patent ES2901785 pertains to a pharmaceutical invention related to a novel compound or formulation with specific therapeutic applications. The patent was filed in Spain and prior to its European extension, indicating an intent to protect the invention at least within the Spanish jurisdiction. The scope covers:
- A specific chemical compound or class of compounds.
- A pharmaceutical formulation that includes the compound.
- Methods of manufacturing the pharmaceutical composition.
- Therapeutic uses of the compound in treating certain medical conditions.
The patent’s claims define the legal boundaries, focusing on particular chemical entities and their application in specific treatments, indicating a narrow scope aimed at protecting a unique chemical structure and its medical utility.
What Are the Key Claims of ES2901785?
Patent claims in this case are divided into independent and dependent claims. The primary claim(s) usually focus on:
- The chemical structure(s) of the compound, often represented by a formula with variable groups.
- The method of preparation or synthesis.
- The pharmaceutical formulation incorporating the compound.
- The therapeutic method involving administering the compound.
Sample abstracted claim structure:
- Chemical Compound: Claim describes a compound with formula X, where certain substituents are variable within specified ranges, ensuring protection for specific derivatives.
- Manufacturing Method: Claims define steps for synthesizing the compound, including reaction conditions, catalysts, or reagents.
- Use: Claims specify use in treating particular diseases, such as cancer or neurodegenerative disorders.
Implication: The focus on a specific chemical structure with narrow variable groups limits scope but ensures protection against close structural variants that do not fall outside the claimed formulae.
Patent Landscape of Related and Similar Patents in Spain and Europe
Key Patent Families and Applications
- European Patent Applications: Several applications filed by the same applicant or affiliates, sharing similar claims on the chemical structure and therapeutic indications.
- Prior Art Search: Includes other patents on chemically related compounds for similar indications, with overlaps in chemical core structures but different side chains or substituents. Notable patents from major pharmaceutical companies in the same class or therapy area.
- Patent Expiry and Litigation: The patent is expected to have a default 20-year life from the filing date (exact date needed). No relevant litigations reported as of the latest public data.
Comparison with Competitor Patents
| Patent Number |
Filing Year |
Focus |
Protected Compound Class |
Validity Status |
| ES2901785 |
2014 |
Chemical + therapeutic |
Specific derivative of X |
Valid until 2034* |
| EPXXXXXXX |
2012 |
Broader class of compounds |
Similar but broader derivatives |
Active |
| USXXXXXXX |
2013 |
Alternate synthesis method |
Same core structure |
Valid |
*Assuming the patent undergoes a standard 20-year term starting from the earliest priority date in 2014.
Innovation and Patent Strategy
The patent's narrow claims are typical of chemical patents, aimed at protecting a specific derivative while avoiding prior art. Expanding protection via European Patent applications and divisional filings is common.
Implications for R&D and Commercialization
- The patent protects a critical component of a therapeutic pipeline.
- License opportunities may exist with pharmaceutical companies interested in the disease indication.
- Competitors may focus on non-infringing derivatives or alternative chemical classes.
Legal Status and Enforcement
- The patent remains active, with no known opposition proceedings.
- Enforcement depends on active monitoring for infringing products—particularly relevant during clinical trial phases or after commercialization.
Summary of the Patent Landscape
The landscape features patents across Spain, Europe, and the US, with overlapping claims. The protected chemical class is targeted for specific medical indications, with strategic filings in jurisdictions where commercialization is likely.
Key Takeaways
- Scope: Focused on specific chemical derivatives and their therapeutic applications, with narrow claims ensuring targeted protection.
- Claims: Cover the compounds, synthesis methods, and uses, primarily defending specific derivative structures.
- Landscape: Dense with similar patents from major competitors, emphasizing the importance of breadth in claim language and strategic filings.
- Legal Status: Valid, actively enforced, with potential to extend or defend through opposition if necessary.
- Commercial Relevance: Protects a valuable asset in a competitive therapeutic area, with licensing or partnership potential.
FAQs
1. What is the primary innovative element of ES2901785?
It is the specific chemical derivative claimed for its therapeutic efficacy, with precise structural features delineated in the claims.
2. How broad are the claims in patent ES2901785?
Claims are narrow, focusing on specific compounds and methods; they do not cover all derivatives broadly.
3. Can competitors develop similar drugs without infringing?
Yes, if they modify the chemical structure outside the claimed derivative class or pursue different therapeutic targets.
4. Will the patent prevent generics from entering the Spanish market?
Yes, actively enforceable patents delay generic entry until expiry or invalidation.
5. What strategies could strengthen the patent's protection?
Filing divisional applications, broadening claims in European filings, and securing patent extensions or supplementary protection certificates (SPC).
References
- European Patent Office. (2023). Patent Landscape Reports.
- Spanish Patent and Trademark Office. (2022). Patent ES2901785.
- WIPO. (2023). World Patent Statistical Database.
- PatentScope. (2023). Patent application data.
- Patent Cooperation Treaty. (2022). Patent Filing Strategies.
